// App-Quantinova.ai

2931 : Validation Of Medical Inpatient Venous Thrombosis Risk Assessment (MITH) Score

Researchers

Presenter

  • Damon E Houghton

Principal Investigators

  • Michael Desarno

  • Peter Callas

  • Allen B Repp

  • Mary Cushman

  • Samuel A Merrill

  • John P. Winters III

  • Neil A Zakai

Medical Centers

  • University of Vermont /Fletcher Allen Hospital, Burlington, VT

  • Fletcher Allen Health Care, Burlington, VT

  • Biostatics Unit, University of Vermont College of Medicine, Burlington, VT

  • University of Vermont /Fletcher Allen Hospital, Burlington, VT

  • Departments of Medicine and Pathology, University of Vermont, Burlington, VT

  • University of Vermont, Burlington, VT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Congestive heart failure

  • Arrhythmia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim